-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A retrospective analysis of 340 black cancer patients participating in the first phase of clinical trials in the United States between 1995 and 2010 showed that the number of CKD-EPI equations that exclude race may reduce the number of black cancer patients deemed eligible for resistance.
If race is excluded from the CKD-EPI equation, as many as 5% and 18% of patients in the analysis will be excluded from treatment or receive lower dose recommendations
The equation of race agnosticism has been proposed, but more work is needed to allow a wide range of clinical applications
The results of the study emphasize the need to consider the use of race-based adjustments, careful and precise clinical judgments, and patient-centered methods to explain and compare the complexity of renal function estimation in different gfr estimation equations
Elimination of race factors in the kidney function-estimating equation is used to guide cancer treatment doses and qualifications that may reduce the proportion of black patients.
The Chronic Kidney Disease-Epidemiology Cooperation (CKD-EPI) equation estimates a key indicator of kidney function, called glomerular filtration rate (GFR)
Since the kidney is the main organ that removes substances from the body, clinicians can use the CKD-EPI equation to help determine the eligibility and dosage of anticancer drugs for cancer patients
Dr.
The co-author of the study, Dr.
The author conducted a retrospective analysis of 340 black patients who were included in the Phase I clinical trial of the National Cancer Institute of the United States from 1995 to 2010
The CKD-EPI equation was used to estimate the patient's renal function, and race was used as a variable
The median glomerular filtration rate calculated by CKD-EPI was 103 mL/min, while the median glomerular filtration rate calculated by CKD-EPI without ethnic factors was 89 mL/min
Since the elimination of race in the CKD-EPI equation reduces the number of patients who are recommended to use or receive full-dose anticancer drugs, the authors admit that doing so may reduce the toxicity of anticancer drugs, but further research is needed
The authors also admit that their research has some limitations
Dr.
DOI 10.
Effect of removing race from glomerular filtration rate-estimating equations on anticancer drug dosing and eligibility: a retrospective analysis of National Cancer Institute phase 1 clinical trial participants